ArticleMolecular cancer therapeutics2024

Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma.

Wenjuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.